Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Top Cited Papers
Open Access
- 1 December 2021
- journal article
- review article
- Published by Springer Nature in Acta Neuropathologica
- Vol. 143 (2) , 179-224
Abstract
In neurological diseases, the actions of microglia, the resident myeloid cells of the CNS parenchyma, may diverge from, or intersect with, those of recruited monocytes to drive immune-mediated pathology. However, defining the precise roles of each cell type has historically been impeded by the lack of discriminating markers and experimental systems capable of accurately identifying them. Our ability to distinguish microglia from monocytes in neuroinflammation has advanced with single-cell technologies, new markers and drugs that identify and deplete them, respectively. Nevertheless, the focus of individual studies on particular cell types, diseases or experimental approaches has limited our ability to connect phenotype and function more widely and across diverse CNS pathologies. Here, we critically review, tabulate and integrate the disease-specific functions and immune profiles of microglia and monocytes to provide a comprehensive atlas of myeloid responses in viral encephalitis, demyelination, neurodegeneration and ischemic injury. In emphasizing the differential roles of microglia and monocytes in the severe neuroinflammatory disease of viral encephalitis, we connect inflammatory pathways common to equally incapacitating diseases with less severe inflammation. We examine these findings in the context of human studies and highlight the benefits and inherent limitations of animal models that may impede or facilitate clinical translation. This enables us to highlight common and contrasting, non-redundant and often opposing roles of microglia and monocytes in disease that could be targeted therapeutically.Keywords
Funding Information
- National Health and Medical Research Council (1088242)
- Merridew Foundation
- Italian Multiple Sclerosis Society (FISM 2019/R-Single/001)
- European Union´s Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement (813294)
This publication has 367 references indexed in Scilit:
- GM-CSF Controls Nonlymphoid Tissue Dendritic Cell Homeostasis but Is Dispensable for the Differentiation of Inflammatory Dendritic CellsImmunity, 2012
- Mouse models of Alzheimer's diseaseBrain Research Bulletin, 2012
- The immunology of stroke: from mechanisms to translationNature Medicine, 2011
- The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C− monocytesNature Immunology, 2011
- Inflammation Induced by Infection Potentiates Tau Pathological Features in Transgenic MiceThe American Journal of Pathology, 2011
- Different Strokes for Different Folks: The Rich Diversity of Animal Models of Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2010
- Neutrophil elastase and neurovascular injury following focal stroke and reperfusionNeurobiology of Disease, 2009
- Selective targeting of perivascular macrophages for clearance of β-amyloid in cerebral amyloid angiopathyProceedings of the National Academy of Sciences, 2009
- Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s diseaseNature, 2008
- Glatiramer acetate fights against Alzheimer’s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1Proceedings of the National Academy of Sciences, 2006